Browse EX-10 agreements

AMENDMENT OF AMENDED AND RESTATED SENIOR SECURED PROMISSORY NOTE

This Amendment of Amended and Restated Senior Secured Promissory Note (this “Amendment”), dated effective as of July 31, 2026 (the “Effective Date”), is entered into by and between R2 Technologies, Inc., a Delaware corporation (the “Company”), and Lancer Capital LLC (“Investor”). Capitalized terms used herein, but not otherwise defined herein, shall have the meaning assigned to them in the Note (as defined below).

RECITALS

WHEREAS, the Company and Investor are parties to that certain Amended and Restated Senior Secured Promissory Note, dated as of August 4, 2025 (the “Note”); and

WHEREAS, the Company and the undersigned Investors desire to amend the Note to extend the Maturity Date as provided herein.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing and for other valuable consideration the receipt of which is hereby acknowledged, the Company and Investor hereby agree as follows:

1.    Maturity Date. Section 1(c)(i) of the Note is hereby amended to read “December 31, 2026.”

…

CONFIRMATION LETTER

Jonathan Dale [_______________]

Re: Confirmation of Terms of Employment

Dear Mr. Dale:

On behalf of Avidbank, a California banking association (the “Bank”), I am pleased to confirm the following terms and conditions of your employment.

| | |

…

EMPLOYMENT AND SEVERANCE AGREEMENT

This Employment and Severance Agreement (the “Agreement”) is entered into on July 31, 2026, effective August 1, 2026 (the “Effective Date”), by and between AGCO CORPORATION, a Delaware corporation (the “Company”), and Indira Agarwal (the “Executive”).

WITNESSETH:

In consideration of the mutual covenants and agreements hereinafter set forth, the Company and the Executive do hereby agree as follows:

**1. **            EMPLOYMENT.

(a)        The Company hereby agrees to employ the Executive, and the Executive hereby agrees to serve the Company, upon the terms and conditions set forth in this Agreement.

(b)       The employment term shall commence August 1, 2026 and shall continue in effect until terminated in accordance with Section 5 of this Agreement.

**2. **            POSITION AND DUTIES.

…

Certain identified information has been excluded from this exhibit (indicated by [**]) because it is both (i) not material and (ii) the type of information that the registrant treats as private or confidential.

* *

PURCHASE AGREEMENT

Fresh From Meijer & True Goodness Herbs

This Purchase Agreement (“Agreement”) dated as of January 1, 2027 (“Effective Date”) is a supplement to the [“Master Terms and Conditions (Rev 07-2023) located at https://vendornet.meijer.com/ (“MTCs”)” or “agreements currently in effect in the VendorNet”] between Edible Garden with its offices at 283 Country Road 519, Belvidere, NJ 07823 (“Company”), and Meijer Distribution, Inc. (“Meijer”).

Company agrees to provide Goods (defined below) in accordance with the terms of this Agreement and the MTCs, which is incorporated in their entirety by reference into this Agreement.

…

SECURITIES PURCHASE AGREEMENT

THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) entered into as of this ____ day of July, 2026 (the “Effective Date”) by and between OPKO Health, Inc., a Delaware corporation (the “Purchaser”), and Cocrystal Pharma, Inc., a Delaware corporation (“COCP”) (collectively, the Purchaser and COCP are the “Parties”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) promulgated thereunder, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement; and

WHEREAS, this Agreement contemplates a transaction in which the Purchasers will purchase from COCP, and COCP will sell to the Purchaser shares of COCP’s common stock (the “Common Stock”) on the terms contained below*.*

…

**AUTOLUS THERAPEUTICS PLC **

**REGISTRATION RIGHTS AGREEMENT **

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of July 30, 2026 by and among AUTOLUS THERAPEUTICS PLC, a public limited company incorporated under the laws of England and Wales (the “Company”), and PERCEPTIVE CREDIT HOLDINGS V, LP, a Delaware limited partnership (the “Investor”).

The parties hereby agree as follows:

1.* Definitions*.

As used in this Agreement, the following terms shall have the following meanings:

“Agreement” has the meaning set forth in the first paragraph.

“Allowed Delay” has the meaning set forth in Section*** 2.3(b)*.

“Blackout Period Payment Date” has the meaning set forth in Section*** 2.4(b)*.

“Blackout Period” has the meaning set forth in Section*** 2.4(b)*.

“Business Day” has the meaning set forth in Section 1.01 of the Purchase Agreement.

“Closing Date” has the meaning set forth in Section 1.01 of the Purchase Agreement.

…

***Execution Version ***

**CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS **

**EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE **

**COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE **

**OMISSIONS HAVE BEEN INDICATED BY “[***].” **

**NOTE PURCHASE AGREEMENT AND GUARANTY **

**dated as of July 30, 2026 **

**by and among **

**AUTOLUS THERAPEUTICS PLC, **

**as the Issuer **

**THE GUARANTORS FROM TIME TO TIME PARTY HERETO **

**as the Guarantors **

**THE NOTEHOLDERS FROM TIME TO TIME PARTY HERETO, **

**as the Noteholders; and **

**PERCEPTIVE CREDIT HOLDINGS V, LP **

**as the Administrative Agent **

**U.S. $250,000,000 **

---

**TABLE OF CONTENTS **

…

Execution Version

ELEVENTH AMENDMENT TO Credit agreement AND guaranty

This Eleventh Amendment to Credit Agreement and Guaranty (this “Amendment”) is made as of July 31, 2026, by and among BIOXCEL THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), the lenders party hereto (collectively, the “Lenders” and individually, a “Lender”), and OAKTREE FUND ADMINISTRATION, LLC, as administrative agent on behalf of the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”).

WHEREAS, the Borrower, the Administrative Agent and the Lenders previously entered into that certain Credit Agreement and Guaranty, dated as of April 19, 2022 (as amended as of November 13, 2023, December 5, 2023, February 12, 2024, March 20, 2024, November 21, 2024, December 6, 2024, March 4, 2025, March 12, 2025, April 22, 2025, March 27, 2026 and July 3, 2026, the “Existing Credit Agreement”, and as further amended by this Amendment, the “Credit Agreement”);

…

VOTING AGREEMENT

This VOTING AGREEMENT (this “Agreement”) is made and entered into as of August 1, 2026, by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (“Supernus”) and the undersigned stockholder (the “Stockholder”) of Indivior Pharmaceuticals, Inc., a Delaware corporation (“Indivior”).

WITNESSETH:

WHEREAS, contemporaneously with the execution of this Agreement, Supernus, Indivior and Artemis Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Indivior (“Merger Sub”) are entering into an Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”);

WHEREAS, pursuant to the Merger Agreement, Merger Sub will merge with and into Supernus (the “Merger”) with Supernus continuing as the surviving corporation and a wholly owned Subsidiary of Indivior;

…

VOTING AGREEMENT

This VOTING AGREEMENT (this “Agreement”) is made and entered into as of August 1, 2026, by and between Indivior Pharmaceuticals, Inc., a Delaware corporation (“Indivior”) and the undersigned stockholder (the “Stockholder”) of Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Supernus”).

WITNESSETH:

WHEREAS, contemporaneously with the execution of this Agreement, Supernus, Indivior and Artemis Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Indivior (“Merger Sub”) are entering into an Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”);

WHEREAS, pursuant to the Merger Agreement, Merger Sub will merge with and into Supernus (the “Merger”) with Supernus continuing as the surviving corporation and a wholly owned Subsidiary of Indivior;

…

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT

THIS SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into this 1st day of August, 2026, by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Jack Khattar (the “Executive”). This Agreement shall become effective only upon, and shall be contingent upon, the consummation of the Merger (as defined below). If the Merger is not consummated, this Agreement shall be null and void and of no force or effect.

WHEREAS, the Executive and the Company originally entered into an amended and restated employment agreement dated February 29, 2012, as amended through the date hereof;

WHEREAS, the Company is merging with and into Artemis Merger Sub Inc., a subsidiary of Indivior Pharmaceuticals Inc. (“Indivior”), pursuant to that certain Agreement and Plan of Merger dated August 1, 2026 (the “Merger Agreement” and such merger, the “Merger”), pursuant to which Merger, the Company shall be the surviving corporation;

…

PROFESSIONAL SERVICES AGREEMENT (PSA)_________________PSA No. _______________

This Professional Services Agreement (PSA) is by and between WhiteFiber, Inc. having a principal place of business at: 31 Hudson Yards, Suite 1130, New York, New York 10001 (hereinafter referred to as the “CLIENT”), and Rasterwerk LLC, a Maryland limited liability company, having a principal place of business at**______________________**, (hereinafter referred to as “Rasterwerk”).

This Agreement sets forth the terms and conditions under which Rasterwerk will provide services to CLIENT for professional services made available by Rasterwerk to CLIENT.

1.  SERVICES. Rasterwerk agrees to perform and CLIENT agrees to pay Rasterwerk for professional services as may be described in one or more Engagement Authorizations signed by the parties (hereinafter the “Services”). Services may be performed at either the CLIENT site or at Rasterwerk’s .

…